121 related articles for article (PubMed ID: 6977255)
1. [Human lymphocyte surface antigens. Part 1. Production and characterization of heteroantisera against cell lines derived from T-cell acute lymphoblastic leukemia and adult T-cell leukemia (author's transl)].
Yoshimoto S
Nihon Ketsueki Gakkai Zasshi; 1981 Nov; 44(6):1153-62. PubMed ID: 6977255
[No Abstract] [Full Text] [Related]
2. Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line.
LeBien TW; Hurwitz RL; Kersey JH
J Immunol; 1979 Jan; 122(1):82-8. PubMed ID: 310838
[No Abstract] [Full Text] [Related]
3. Subset derivation of T-cell acute lymphoblastic leukemia in man.
Reinherz EL; Nadler LM; Sallan SE; Schlossman SF
J Clin Invest; 1979 Aug; 64(2):392-7. PubMed ID: 313405
[TBL] [Abstract][Full Text] [Related]
4. Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.
van Dongen JJ; Geurts van Kessel AH; Wolvers-Tettero IL; Versnel MA; van Oudenaren A; Schoenmaker E; Hagemeijer A
J Immunol; 1986 Aug; 137(3):1047-53. PubMed ID: 3487584
[TBL] [Abstract][Full Text] [Related]
5. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
Koshiba H; Minowada J; Pressman D
J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
Haynes BF; Metzgar RS; Minna JD; Bunn PA
N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
[TBL] [Abstract][Full Text] [Related]
7. Recognition by human and rabbit sera of common antigens to leukemia blast cells, peripheral blood B-lymphocytes, and monocytes.
Zighelboim J; Bick A; Durantez A
Cancer Res; 1977 Oct; 37(10):3656-62. PubMed ID: 71197
[TBL] [Abstract][Full Text] [Related]
8. [Human lymphocyte surface antigens. Part 2. Production and characterization of heteroantiserum against a B-cell acute lymphoblastic leukemia cell line].
Yoshimoto S
Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):737-43. PubMed ID: 6332446
[No Abstract] [Full Text] [Related]
9. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
10. [Acute lymphoblastic leukemia of T-precursor cell--special reference to surface marker (author's transl)].
Kawashima K; Kato Y; Ogura M; Suzuki H; Watanabe E; Takamatsu J; Minami S; Isobe K; Nagura E; Yamada K; Iwamura H; Yamamura M; Yokomaku S
Rinsho Ketsueki; 1981 Jul; 22(7):1102-8. PubMed ID: 6977046
[No Abstract] [Full Text] [Related]
11. Human leukemia antigen. I. Production and characterization of antisera.
Billing R; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
[No Abstract] [Full Text] [Related]
12. Immunophenotypic characterization and classification of T-acute lymphoblastic leukemia. Report of 30 cases.
Ferrara F; Cimino R; De Rosa C; Lo Pardo C; Montuori R; Pace E; Vacca C; Del Vecchio L
Haematologica; 1987; 72(3):227-31. PubMed ID: 3114088
[No Abstract] [Full Text] [Related]
13. Acute lymphoblastic leukemia: classification and characterization with antisera to human T-cell and Ia antigens.
Anderson JK; Moore JO; Falletta JM; Terry WF; Metzgar RS
J Natl Cancer Inst; 1979 Feb; 62(2):293-8. PubMed ID: 310908
[No Abstract] [Full Text] [Related]
14. [A case of T cell acute lymphoblastic leukemia characterized by sequentially changing surface markers (author's transl)].
Kuroda I; Uema T; Nakahata T; Miyagawa Y; Komiyama A; Akabane T
Rinsho Ketsueki; 1979 Feb; 20(2):157-63. PubMed ID: 312334
[No Abstract] [Full Text] [Related]
15. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
Galli SJ; Adams RA
Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
[No Abstract] [Full Text] [Related]
16. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
17. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
18. Heteroantisera against a blast cell antigen.
Billing R; Terasaki PI; Clark B
Clin Immunol Immunopathol; 1979 Aug; 13(4):435-43. PubMed ID: 90573
[No Abstract] [Full Text] [Related]
19. [Establishment and characterization of B cell line cells (Kei-4 and Kei-5) derived from a patient with adult T-cell leukemia].
Yasuda K
Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):784-93. PubMed ID: 2994339
[No Abstract] [Full Text] [Related]
20. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.
Minowada J; Onuma T; Moore GE
J Natl Cancer Inst; 1972 Sep; 49(3):891-5. PubMed ID: 4567231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
